Last: | $1.95 |
---|---|
Change Percent: | -7.18% |
Open: | $1.94 |
Close: | $1.95 |
High: | $2.06 |
Low: | $1.94 |
Volume: | 29,656 |
Last Trade Date Time: | 12/27/2022 03:19:22 pm |
Quotes are delayed by 15 to 20 minutes.
Last | Open | Close | High | Low | Volume | Date |
---|---|---|---|---|---|---|
$1.95 | $1.94 | $1.95 | $2.06 | $1.94 | 29,656 | 12-27-2022 |
$1.81 | $1.95 | $1.81 | $2.075 | $1.81 | 49,649 | 12-26-2022 |
$1.81 | $1.95 | $1.81 | $2.075 | $1.81 | 49,649 | 12-23-2022 |
$1.96 | $1.83 | $1.96 | $1.98 | $1.83 | 3,476 | 12-22-2022 |
$1.8 | $1.811 | $1.8 | $2 | $1.79 | 45,038 | 12-21-2022 |
$1.81 | $1.75 | $1.81 | $1.89 | $1.7 | 127,057 | 12-20-2022 |
$1.79 | $2.35 | $1.79 | $2.35 | $1.5 | 101,512 | 12-19-2022 |
$2.61 | $2.64 | $2.61 | $2.64 | $2.6027 | 1,003 | 12-16-2022 |
$2.66 | $2.37 | $2.66 | $2.66 | $2.37 | 705 | 12-15-2022 |
$2.72 | $2.93 | $2.72 | $2.93 | $2.72 | 1,460 | 12-14-2022 |
$3 | $2.96 | $3 | $3 | $2.96 | 442 | 12-13-2022 |
$2.97 | $2.7 | $2.97 | $3 | $2.7 | 3,314 | 12-12-2022 |
$2.66 | $2.69 | $2.66 | $2.69 | $2.66 | 398 | 12-09-2022 |
$2.8523 | $2.8523 | $2.8523 | $2.8523 | $2.8523 | 1,325 | 12-08-2022 |
$2.92 | $2.9719 | $2.92 | $2.9719 | $2.72 | 2,170 | 12-07-2022 |
$3.19 | $2.8 | $3.19 | $3.19 | $2.4 | 3,856 | 12-06-2022 |
$2.81 | $0 | $2.81 | $0 | $0 | 166 | 12-05-2022 |
$2.81 | $2.8001 | $2.81 | $2.8968 | $2.8001 | 753 | 12-02-2022 |
$2.945 | $2.8 | $2.945 | $3.02 | $2.8 | 4,405 | 12-01-2022 |
$2.97 | $2.9538 | $2.97 | $3.075 | $2.8 | 1,753 | 11-30-2022 |
News, Short Squeeze, Breakout and More Instantly...
COPENHAGEN, Denmark, Dec. 19, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we” or “Forward”), today announced that that on December 16, 2022 it received written notice from The Nasdaq Stock Market LLC (“Nasdaq”) notifying us that Nasdaq beli...
COPENHAGEN, Denmark, Dec. 06, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“Forward” or the “Company”), today announced that the Enlarged Board of Appeal (the “EBA”) of the European Patent Office (the “EPO”) has denied Forward...
COPENHAGEN, Denmark, April 08, 2022 (GLOBE NEWSWIRE) -- Forward Pharma A/S (NASDAQ:FWP) (“we,” “Forward” or the “Company” and, together with its subsidiaries, the “Group”), today reported consolidated financial results for the year end...